Population and Public Health

Mold Toxicity: A Personal Battle and Call for Better Care
Public Policy Mold Toxicity: A Personal Battle and Call for Better Care

In a quiet Miami apartment, what began as a seemingly innocuous move for Ariana Thacker turned into a life-altering health crisis that millions unknowingly face, revealing a hidden public health issue. Subtle hints of trouble, like lingering fatigue and a faint musty odor, were easy to dismiss as

How Can Rapid Testing Combat Antibiotic Resistance?
Care How Can Rapid Testing Combat Antibiotic Resistance?

What happens when the very drugs meant to heal become a hidden threat to humanity’s future? Each year in the United States, nearly 3 million infections defy standard antibiotics, claiming over 35,000 lives, and this silent epidemic, fueled by overprescribing in high-pressure settings like urgent c

Transforming Youth Suicide Prevention in Pediatric Care
Care Transforming Youth Suicide Prevention in Pediatric Care

I'm thrilled to sit down with Faisal Zain, a renowned healthcare expert with a deep focus on medical technology. With years of experience in the manufacturing of medical devices for diagnostics and treatment, Faisal has been at the forefront of innovation in healthcare. Today, we're

Florida Group Pushes Medicaid Expansion for 2026 Ballot
Public Policy Florida Group Pushes Medicaid Expansion for 2026 Ballot

I'm thrilled to sit down with Faisal Zain, a renowned healthcare expert with a deep background in medical technology and innovation. With years of experience in the manufacturing of medical devices for diagnostics and treatment, Faisal brings a unique perspective to the pressing issue of

CDC Shakeup: Monarez’s Exit Sparks Vaccine Policy Debate
Public Policy CDC Shakeup: Monarez’s Exit Sparks Vaccine Policy Debate

I'm thrilled to sit down with Faisal Zain, a renowned healthcare expert with a deep background in medical technology. With years of experience in the manufacturing of medical devices for diagnostics and treatment, Faisal has been at the forefront of innovation in the field. Today, we'll

FDA Suspends Valneva’s Chikungunya Vaccine Over Safety Risks
Public Policy FDA Suspends Valneva’s Chikungunya Vaccine Over Safety Risks

What happens when a long-awaited solution to a debilitating disease turns into a potential threat? In a stunning turn of events, the U.S. Food and Drug Administration (FDA) has suspended the license of Ixchiq, the first chikungunya vaccine approved in the U.S., developed by Valneva, a France-based

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later